SIRT6 and glycogen storage disease VI: In 2012, Kanfi et al. showed that transgenic mice overexpressing SIRT6 had a remarkably longer lifespan than their wild-type littermates, suggesting that SIRT6 has important therapeutic potential in aging-related diseases [62].